Endologix Inc

Endologix develops and manufactures minimally invasive treatments for vascular diseases. The company, working with leading practitioners to develop technology solutions for life-threatening medical conditions, is engaged in the development, manufacture, sales and marketing of minimally invasive therapies for the treatment of aortic aneurysms. Once an aneurysm develops, it continues to enlarge and if left untreated becomes increasingly susceptible to rupture. It is the cause of death for more than 15,000 people each year in the United States. Endologix's patented Powerlink System is a unibody self-expandable device with a durable frame made of stainless steel alloy covered with an expanded polytetrafluoroethylene graft. The one-piece bifurcated design featuring a fully supported stent cage was developed to overcome the many shortcomings associated with earlier-generation endoluminal graft devices. Endologix is headquartered in Irvine, Calif.

Tekia Inc., located in Irvine, California, specializes in the development and distribution of advanced intraocular lenses (IOLs) designed to enhance vision, particularly with features that support near vision capabilities. Their product line includes various IOL types, such as hydrophobic and hydrophilic options, as well as specialized injectors and guidance for surgeons. The company is committed to quality and safety, as evidenced by their certifications including CE Marks and other relevant licenses. With a focus on innovation and user needs, Tekia Inc. continues to contribute to the field of ophthalmology through their cutting-edge lens solutions and support resources. Generated from the website

Founded in 1989, CardioGenesis Corporation is a medical device company that designs, manufactures and distributes laser-based surgical products that promote cardiac angiogenesis. The company produces laser devices for the percutaneous myocardial revascularization procedure and is the only company conducting trials of percutaneous myocardial revascularization. Its focus is on patients with advanced cardiovascular disease and specifically severe angina. CardioGenesis products include a CardioGenesis TMR 2000, a solid-state Holmim:YAG Laser System that delivers laser energy to the heart muscle through the CardioGenesis SoloGrip III, a surgical hand-piece with built-in fiberoptics. More than 10,000 of these procedures have been performed worldwide. The company holds more than 90 United States and international patents. CardioGenesis is headquartered in Foothill Ranch, Calif.